Voyager Therapeutics Inc — Quarterly Cash Flow (NASDAQ:VYGR) | MetaTrader

Open full chart

Financials

Overview Rapor Statistics Dividends

Quarterly Annual

Total assets 426.04 M393.05 M353.24 M322.1 M288.31 M Total liabilities 95.73 M93.29 M80.54 M78.16 M68.49 M Total equity 330.31 M299.76 M272.7 M243.94 M219.82 M Total liabilities & shareholders' equities 426.04 M393.05 M353.24 M322.1 M288.31 M Total debt ————— Net debt —————

Haberler

Fortrea Holdings Inc. (FTRE) Q4 Earnings and Revenues Lag Estimates

Alzheimer's Clinical Trial Results, Sadly Running True To Form

J&J Halts Alzheimer's Trial After Drug Fails To Slow Clinical Decline - Johnson & Johnson (NYSE:JNJ)

H.C. Wainwright, Voyager Therapeutics için hedef fiyatını 25 dolara düşürdü

Voyager Therapeutics stock price target lowered to $25 at H.C. Wainwright

Voyager Therapeutics Stifel Konferansında: Nöroterapötik Yenilikler

Voyager Therapeutics at Stifel Conference: Neurotherapeutic Innovations

Leerink Partners, Voyager Therapeutics için hedef fiyatı 12 dolara yükseltti

Voyager Therapeutics stock price target raised to $12 by Leerink Partners

Voyager Therapeutics Inc kazancı $0,05 ile beklentilere göre daha iyi, kâr ise beklentilere göre yüksek

Voyager Therapeutics Inc earnings beat by $0.05, revenue topped estimates

Voyager Therapeutics (VYGR) Reports Q3 Loss, Tops Revenue Estimates